Table 1. Summary of reported cases of KS in psoriasis patients.
| Author | No. | Age (yr)/sex | Type of KS | Duration of psoriasis (yr) | Comorbidities | Suspected cause of KS (duration of treatment) |
|---|---|---|---|---|---|---|
| Philipp et al.1 | 1 | 60/M | Iatrogenic | 40 | - | Fumaric acid esters (25 months) |
| Tebbe et al.2 | 2 | 59/M | Iatrogenic | 46 | Chronic obstructive lung disease | Prednisolone treatment (5 months) |
| Dervis and Demirkesen3 | 3 | 54/F | Classic | 29 | Hypertension | Cilazapril (ACEi) (9 months) |
| Sorce and Bongiorno6 | 4 | 74/F | Classic | 15 | Hypertension, vitiligo, monoclonal gammopathy of undetermined significance | Immune dysregulation underlying chronic inflammatory disorders |
| Verdelli et al.7 | 5 | 78/F | Iatrogenic | - | - | Tocilizumab (13 months) |
| Ursini et al.8 | 6 | 49/M | Iatrogenic | 9 | Diabetes mellitus | Infliximab (15 months) |
| Selvi et al.9 | 7 | 75/F | Iatrogenic | 30 | - | Intra-articular steroid injection for psoriatic arthritis |
| Fargnoli et al.10 | 8 | 56/M | Classic | 20 | Down syndrome, Hodgkin’s lymphoma |
Down syndrome-related compromised immune surveillance |
| Häring et al.11 | 9 | 46/M | Classic | 10 | - | UV light therapy |
| Our case | 71/M | Classic | 10 | Hypertension | Unknown, maybe due to immune dysregulation under chronic inflammatory dermatosis, psoriasis |
KS: Kaposi's sarcoma, M: male, F: female, -: not mentioned, ACEi: angiotensin-converting enzyme inhibitor, UV: ultraviolet.